- Home
- ALNY vs MLM Comparison
ALNY vs MLM Comparison
Compare ALNY & MLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- MLM
- Stock Information
- Founded
- ALNY 2002
- MLM 1993
- Country
- ALNY United States
- MLM United States
- Employees
- ALNY N/A
- MLM N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- MLM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- ALNY Health Care
- MLM Industrials
- Exchange
- ALNY Nasdaq
- MLM Nasdaq
- Market Cap
- ALNY 33.2B
- MLM 33.2B
- IPO Year
- ALNY 2004
- MLM 1994
- Fundamental
- Price
- ALNY $264.99
- MLM $552.66
- Analyst Decision
- ALNY Buy
- MLM Strong Buy
- Analyst Count
- ALNY 24
- MLM 15
- Target Price
- ALNY $299.09
- MLM $645.86
- AVG Volume (30 Days)
- ALNY 643.5K
- MLM 393.4K
- Earning Date
- ALNY 02-13-2025
- MLM 02-12-2025
- Dividend Yield
- ALNY N/A
- MLM 0.55%
- EPS Growth
- ALNY N/A
- MLM 86.63
- EPS
- ALNY N/A
- MLM 32.12
- Revenue
- ALNY $2,094,795,000.00
- MLM $6,513,200,000.00
- Revenue This Year
- ALNY $24.87
- MLM N/A
- Revenue Next Year
- ALNY $18.53
- MLM $10.22
- P/E Ratio
- ALNY N/A
- MLM $17.20
- Revenue Growth
- ALNY 21.54
- MLM N/A
- 52 Week Low
- ALNY $141.98
- MLM $490.05
- 52 Week High
- ALNY $304.39
- MLM $633.23
- Technical
- Relative Strength Index (RSI)
- ALNY 61.89
- MLM 60.07
- Support Level
- ALNY $245.69
- MLM $526.10
- Resistance Level
- ALNY $256.93
- MLM $521.97
- Average True Range (ATR)
- ALNY 9.38
- MLM 9.22
- MACD
- ALNY 2.95
- MLM 5.75
- Stochastic Oscillator
- ALNY 99.91
- MLM 86.37
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About MLM Martin Marietta Materials Inc.
Martin Marietta Materials is one of the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). In 2023, Martin Marietta sold 199 million tons of aggregates. Martin Marietta's most important markets include Texas, Colorado, North Carolina, Georgia, and Florida, accounting for most of its sales. The company also produces cement in Texas and uses its aggregates in its asphalt and ready-mixed concrete businesses. Martin's magnesia specialties business produces magnesia-based chemical products and dolomitic lime.